SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

04 Nov 2022 Evaluate
A minor change in the total revenue was seen in the September 2022 quarter. The total revenue for the quarter stood at Rs. 1107.19 millions against Rs. 1103.82 millions during year ago period.Net Profit of the company move down -35.69% to Rs. 127.64  millions from Rs. 198.47 millions  in the same quarter last year.Operating profit for the quarter ended September 2022 decreased to 189.61 millions as compared to 272.29 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1107.19 1103.82 0.31 1816.73 1885.94 -3.67 4058.42 3328.44 21.93
Other Income 30.32 42.85 -29.24 60.44 70.24 -13.95 153.83 113.20 35.89
PBIDT 189.61 272.29 -30.36 253.03 445.20 -43.16 948.56 860.73 10.20
Interest 0.20 0.69 -71.01 0.44 1.54 -71.43 4.85 5.00 -3.00
PBDT 189.41 271.60 -30.26 252.59 443.66 -43.07 943.71 855.73 10.28
Depreciation 15.21 8.05 88.94 25.88 17.25 50.03 37.95 36.70 3.41
PBT 174.20 263.55 -33.90 226.71 426.41 -46.83 905.76 819.03 10.59
TAX 46.56 65.08 -28.46 62.43 107.37 -41.86 233.88 207.14 12.91
Deferred Tax 0.00 0.00 0.00 -1.74 0.00 0.00 0.00 0.00 0.00
PAT 127.64 198.47 -35.69 164.28 319.04 -48.51 671.88 611.89 9.80
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 17.13 24.67 -30.58 13.93 23.61 -41.00 23.37 25.86 -9.62

Amrutanjan Healthcar Share Price

543.15 -3.35 (-0.61%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×